1Bayes-Rusinol A, Forjaz MJ, Ayala A, et al. Awareness of dysphagia in Parkinson's disease[J]. Rev Neurol,2011,53 (1):664-672.
2Cupidi C, Realmuto S, LoCo G, et al. Sleep quality in care givers of patients with Alzheimerrs disease and Parkinson s disease and its relationship to quality of life[J]. Int Psy chogeriatr, 2012,24(11) : 1827-1835.
3Rod NH, Bordelon Y, Thompson A, et al. Major life e- vents and development of major depression in Parkinson's disease patients[J]. Eur J Neruol,2013,20(4):663-670.
4Ravina B,Elm J,Camicioli R,et al. The course of depres- sive symptoms in early Parkinson's disease[J]. Mov Dis- ord,2009,20(24) :1306-1311.
5Weerkamp NJ, Tissingh G, Poesl PJ, et al. Nonmotor symptoms in nursing home residents with Parkinsonr s disease : prevalence and effect on quality of life[J]. J Am Geriatr, 2013,61 (10) : 1714-1721.
6Gerlach M, Halley P, Riederer P, et al. The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson' s disease: differential role of alpha (2) ad- renergic mechanisms[J]. J Neural Transm,2013,120(1) : 31-36.
7Thobois S, Lhommee E, Klinger H, et al. Parkinsonian ap- athy responds to dopaminergic stimulation of D2/D3 re- ceptors with piribedil[J]. Brain,2013,136(5) : 1568-1577.
8Herzallah MM, Moustafa AA, Nastheh JY, et al. Depres- sion impairs learning, whereas the selective serotonin re- uptake inhibitor, paroxetine, impairs generalization in pa- tients with major depressive disorder[J]. J Affec Disord, 2013,151(2) : 484-492.
9Jesse S, Kassubek J, Muller HP, et al. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis[J]. BMC Neurol,2012,12 : 163.
